Europe’s health regulator approved a third booster of the Pfizer vaccine for healthy adults from 18 and older.
The European Medicines Agency’s committee recommended the dose based on a study that exhibited a surge of antibodies in the third shot administered for 18 to 55-year-olds.
The EMA added, “The Committee concluded that booster doses may be considered at least 6 months after the second dose for people aged 18 years and older.”
The EMA also said that people with immune deficiencies may be given either a Pfizer or Moderna booster shot 28 days after being administered their second dose.
The regulator’s recommendations are subject to the approval of the European Commission and then to officials from the 27 EU nations, where some have already begun initiating booster shots to people.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.